Latest BMRN reports update at 2024-04-26: 2024-Q12023-Q42023-Q1
BioMarin Pharmaceutical  logo
BioMarin Pharmaceutical BMRN
$ 81.72 -0.13%

BioMarin Pharmaceutical Financial Ratios 2011-2024 | BMRN

Annual Financial Ratios BioMarin Pharmaceutical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

100.8 134.6 -252.1 18.6 -639.6 -222.4 -134.3 -22.5 -68.9 -106.1 -54.3 -57.0 -74.1

P/S

7.0 9.1 8.8 8.5 9.0 11.5 12.0 12.7 13.3 18.9 17.5 13.0 9.0

EPS

0.9 0.8 -0.3 4.7 -0.1 -0.4 -0.7 -3.8 -1.1 -0.9 -1.3 -0.9 -0.5

EV (Enterprise Value)

18 B 20.1 B 17.3 B 16.9 B 16.4 B 18.1 B 16.9 B 15 B 12.8 B 14.3 B 9.92 B 6.92 B 4.48 B

EBITDA per Share

1.4 1.36 0.14 0.34 -0.287 -0.704 -0.534 -1.39 -1.87 -0.973 -0.997 -0.761 -0.29

EV/EBITDA

670.7 -531.8 -305.1 -140.3 -174.8 -62.6 -40.5 -98.3 -70.4 -73.0 -132.3

PEG

0.94 1.19 3.44 -0.28 -9.11 -6.37 -1.63 0.09 4.23 -3.77 1.56 0.58 0.6

P/B

3.4 4.1 3.8 3.9 4.9 5.8 5.6 5.1 4.9 9.3 7.1 6.4 5.2

P/CF

106.1 108.3 53.0 185.7 -132.5 -138.0 -75.6 -37.7 -26.4 -73.9 -76.8 -241.6 -29.5

ROE %

3.39 3.08 -1.50 20.83 -0.76 -2.60 -4.17 -22.78 -7.16 -8.77 -13.15 -11.26 -6.96

ROA %

2.45 2.22 -1.07 14.60 -0.51 -1.74 -2.53 -15.66 -4.61 -5.38 -7.84 -7.14 -4.13

ROCE %

3.19 3.25 -1.93 -1.06 -3.34 -4.44 -3.66 -5.70 -8.57 -7.11 -7.55 -7.70 -2.80

Current Ratio

3.6 3.6 3.5 3.4 2.1 3.9 2.7 3.2 2.4 6.0 6.2 4.4 5.0

DSO

82.6 72.7 81.2 81.0 80.8 83.9 72.6 70.4 73.5 97.8 78.4 79.5 91.7

DIO

709.4 630.4 572.2 480.0 690.7 614.6 718.2 618.4 652.4 561.0 619.9 511.5 565.2

DPO

- - - - 244.7 240.4 251.5 333.2 430.5 369.2 363.3 266.9 53.2

Operating Cycle

792.0 703.1 653.4 561.0 771.6 698.5 790.9 688.7 725.8 658.8 698.3 591.0 657.0

Cash Conversion Cycle

792.0 703.1 653.4 561.0 526.9 458.1 539.3 355.5 295.3 289.5 335.0 324.1 603.8

All numbers in USD currency

Quarterly Financial Ratios BioMarin Pharmaceutical

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.47 - 0.21 0.3 0.27 - -0.04 0.15 0.66 - -0.2 0.07 0.1 - 4.33 -0.16 0.45 - 0.31 -0.21 -0.32 - -0.07 -0.09 -0.25 - -0.07 -0.21 -0.09 - -0.22 -2.58 -0.51 - -0.57 -0.51 -0.43 - 0.05 -0.23 -0.26 - -0.38 -0.15 -0.31 - -0.04 -0.27 -0.21 - -0.16 -0.05 -0.04

EBITDA per Share

0.61 - 0.19 0.36 0.48 - 0.03 0.26 0.89 - 0.16 0.13 0.29 - 0.12 0.06 0.73 - 0.47 0.04 -0.18 - 0.31 0.11 -0.12 - 0.26 - - - 0.1 -3.23 -0.38 - -0.3 -0.26 -0.35 - 0.35 0.05 -0.1 - -0.09 0.03 -0.17 - 0.19 -0.08 -0.1 - 0.1 0.16 0.1

ROE %

4.57 3.09 2.94 1.97 1.42 3.22 2.37 1.66 1.35 -0.13 18.98 38.95 37.93 20.38 22.15 4.80 4.31 -1.24 -1.67 -3.86 -3.22 -2.48 -2.92 -2.95 -3.69 -2.34 -3.69 -4.60 -18.43 -19.50 -23.29 -25.72 -13.99 -10.01 -9.53 -5.25 -4.03 -4.20 -8.15 -12.59 -12.01 -8.53 -9.06 -5.63 -7.17 -6.04 -8.32 -10.08 -7.58 -3.51 -2.28 -0.66 -0.57

ROA %

3.34 2.24 2.14 1.43 2.57 3.88 3.27 0.77 0.99 -0.09 13.33 27.36 26.64 14.31 15.49 3.24 2.94 -0.83 -1.11 -2.57 -2.15 -1.66 -1.93 -1.92 -2.33 -1.42 -2.35 -3.01 -12.63 -13.41 -15.85 -17.35 -9.14 -6.45 -6.15 -3.41 -2.56 -2.58 -4.94 -7.60 -7.22 -5.10 -5.43 -3.40 -4.44 -3.83 -5.18 -6.20 -4.59 -2.08 -1.35 -0.39 -0.34

ROCE %

4.02 3.09 3.04 2.46 2.10 3.95 2.70 1.50 0.91 -0.37 -1.73 -1.85 -3.12 0.20 0.33 1.82 1.49 -2.92 -3.45 -4.11 -3.64 -2.88 -3.37 -3.32 -3.85 -2.59 -4.76 -6.45 -25.77 -25.80 -29.21 -30.45 -12.42 -8.83 -8.10 -3.95 -2.51 -2.23 -6.02 -10.53 -10.79 -7.73 -8.77 -6.02 -7.57 -6.23 -8.24 -9.21 -6.07 -1.61 -2.01 0.10 0.30

Current Ratio

3.8 3.6 3.6 3.7 3.6 3.6 3.7 - 3.6 3.5 3.5 3.6 3.5 3.4 3.4 3.4 3.4 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 2.5 2.5 2.5 2.5 3.2 3.2 3.2 3.2 2.8 2.8 2.8 2.8 2.6 2.6 2.6 2.6 2.5 2.5 2.5 2.5 2.8 2.7 2.7 2.7 2.5 2.5 2.5 2.5

DSO

89.4 - 92.8 92.6 81.0 - 37.9 36.8 70.6 - 89.2 74.6 79.3 - 85.8 95.3 75.0 - 74.7 88.8 82.0 - 79.8 83.9 73.8 - 71.4 75.1 71.6 - 70.2 65.5 73.3 - 72.0 60.2 69.6 - 74.7 68.7 79.0 - 78.5 78.6 80.9 - 77.7 80.2 83.7 - 84.3 86.5 -

DIO

818.3 - 734.3 674.8 610.6 - 329.4 291.4 609.7 - 643.5 511.6 536.3 - 337.6 650.6 564.8 - 640.3 801.6 619.6 - 614.0 613.0 557.8 - 729.9 771.1 758.1 - 638.7 627.8 663.2 - 710.3 651.3 693.5 - 608.3 583.1 724.0 - 528.9 657.5 648.3 - 477.0 498.1 690.3 - 529.0 616.4 -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 34.2 59.6 83.0 - 90.6 79.7 139.3 - 120.0 149.2 135.5 - 88.9 92.9 96.6 - 49.8 58.0 -

Operating Cycle

907.7 - 827.1 767.4 691.6 - 367.2 328.2 680.3 - 732.8 586.3 615.6 - 423.4 745.9 639.9 - 715.0 890.4 701.6 - 693.8 696.9 631.6 - 801.3 846.2 829.7 - 708.9 693.2 736.5 - 782.3 711.5 763.0 - 683.0 651.9 803.0 - 607.5 736.1 729.2 - 554.7 578.4 774.0 - 613.3 702.9 -

Cash Conversion Cycle

907.7 - 827.1 767.4 691.6 - 367.2 328.2 680.3 - 732.8 586.3 615.6 - 423.4 745.9 639.9 - 715.0 890.4 701.6 - 693.8 696.9 631.6 - 801.3 846.2 829.7 - 708.9 693.2 736.5 - 748.1 651.9 680.0 - 592.4 572.2 663.6 - 487.4 586.9 593.7 - 465.8 485.5 677.4 - 563.6 644.9 -

All numbers in USD currency